SCHEMBL19225163

SCHEMBL19225163

O=C1Nc2ccccc2NC12CCC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE7A Q13946 4/20 0.47
▸ ACAT2 Q9BWD1 1/20 0.41
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ BACE1 P56817 1/20 0.39
▸ PDK2 Q15119 1/20 0.38
▸ PDK4 Q16654 1/20 0.38
▸ BRD4 O60885 3/20 0.38
▸ CREBBP Q92793 2/20 0.38
▸ EP300 Q09472 1/20 0.38
▸ CRBN Q96SW2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ MGAT2 Q10469 1/20 0.36
▸ MAOA P21397 1/20 0.36
▸ MAOB P27338 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10758073 0.94 PDE7A (0.54) PDE7AACAT2KMT2AMEN1POLB
SCHEMBL17350152 0.92 PDE7A (0.42) PDE7AKMT2AMEN1POLBGAA
SCHEMBL30552386 0.85 BACE1 (0.47) PDE7AACAT2KMT2AMEN1POLB
SCHEMBL3516954 0.77 BACE1 (0.50) PDE7AKMT2AMEN1POLBGAA
SCHEMBL30552358 0.77 CRBN (0.56) GAACRBNALDH1A1KDM4E
SCHEMBL30552354 0.77 CRBN (0.56) GAACRBNALDH1A1KDM4E
SCHEMBL17524916 0.73 SCN9A (0.43) KMT2AMEN1POLBGAAMAPK1
SCHEMBL12748916 0.73 PDE7A (0.37) PDE7AKMT2AMEN1GAAALDH1A1
SCHEMBL13757008 0.73 PDE7A (0.41) PDE7ACREBBPMGAT2
SCHEMBL29022614 0.72 CRBN (0.48) KMT2AMEN1MAPK1CRBNALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250145621-A1 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS INCYTE HOLDINGS CORPORATION 2025-05-08 — — US disclosed
US-20170224713-A1 HETEROCYCLIC COMPOUNDS FOR TREATING OR PREVENTING DISORERS CAUSED BY REDUCED NEUROTRANSMISSION OF SEROTONIN, NOREPHNEPHRINE OR DOPAMINE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2017-08-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170224713-A1 HETEROCYCLIC COMPOUNDS FOR TREATING OR PREVENTING DISORERS CAUSED BY REDUCED NEUROTRANSMISSION OF SEROTONIN, NOREPHNEPHRINE OR DOPAMINE HCRTR1, NPSR1, NTSR1 PDE7A 1579/4885ACAT2 3837/4885KMT2A 3263/4885
US-20250145621-A1 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS BRD3, BRD1, BRD2 PDE7A 3690/4885ACAT2 3095/4885KMT2A 655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback